Table 2 Efficacy and safety outcomes in patients who underwent PCI at baseline with those who did not undergo PCI
PCI | No PCI | P value | |
|---|---|---|---|
Number (%) | 401 (48.3) | 429 (51.7) | |
Composite primary endpoints (n) | 14 | 14 | 0.931 |
Secondary efficacy endpoints (n) | 62 | 65 | 0.946 |
Cardiovascular death (n) | 4 | 6 | 0.348 |
Myocardial infarction (n) | 5 | 2 | 0.234 |
Stroke (n) | 7 | 4 | 0.328 |
Hospitalization for UA (n) | 33 | 34 | 0.879 |
Urgent revascularization (n) | 22 | 10 | 0.027 |
TIMI major bleeding (n) | 9 | 1 | 0.009 |
TIMI minor bleeding (n) | 71 | 39 | 0.002 |
Intracranial hemorrhage (n) | 2 | 0 | 0.149 |
Dyspnea (n) | 64 | 38 | 0.004 |
Bradycardia (n) | 20 | 6 | 0.002 |